Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early versus late fixed-start Cetrotide protocol in IVF/ICSI
NL-OMON37107Phase 4Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Mar 2009
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cetrorelix and follicle-stimulating hormone in infertility (2 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Live birth rate per started cycle. Started Mar 2009; status: active, not recruiting.
02
Drugs
cetrorelixfollicle-stimulating hormone
03
Conditions
infertility
Beyond the preview
Go deeper on NL-OMON37107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37107.